<DOC>
	<DOCNO>NCT02351726</DOCNO>
	<brief_summary>Prospective , non-randomized , multicenter post-approval study collect long term clinical echographic data Mitroflow DL patient .</brief_summary>
	<brief_title>Mitroflow DL Post Approval Study- North America</brief_title>
	<detailed_description>The purpose clinical investigation evaluate safety efficacy Mitroflow DL valve use replace diseased dysfunctional native prosthetic aortic heart valve . The study conduct minimum 15 center United States . Patients evaluate following time interval : preoperative , implant , early postoperative period , 1 year ( 11 13 month postoperatively ) , annually 8 year . The duration study anticipate 8 year .</detailed_description>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Congenital Abnormalities</mesh_term>
	<mesh_term>Aortic Valve Stenosis</mesh_term>
	<mesh_term>Heart Valve Diseases</mesh_term>
	<mesh_term>Aortic Valve Insufficiency</mesh_term>
	<mesh_term>Cardiovascular Abnormalities</mesh_term>
	<mesh_term>Pathological Conditions , Anatomical</mesh_term>
	<criteria>1 . Patients indicate Mitroflow DL implantation accord Instructions Use ( IFU ) . 2 . Patient patient 's legal representative willing sign inform consent . 3 . Patient 's preoperative evaluation indicate need native prosthetic aortic valve replacement 4 . Any patient amenable aortic valve replacement biological prosthesis enrol study , even conjuction valve repair , coronary artery bypass grafting procedure 5 . Patient able return followup evaluation duration study ( geographically stable ) . 1 . Patient contraindicate Mitroflow DL implantation accord Instructions Use . 2 . The patient preexist valve prosthesis mitral , pulmonary , tricsupid position . 3 . Patient require double triple valve replacement ( repair consider exclusion ) . 4 . Patient active endocarditis myocarditis . 5 . Patient pregnant lactating . 6 . Patient participate concomitant research study investigational product .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>aortic valve replacement</keyword>
	<keyword>aortic stenosis</keyword>
	<keyword>aortic steno-insufficiency</keyword>
</DOC>